Richwood Investment Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
SLAM
CWP
Richwood Investment Advisors's PFE Position: Q2 2026 in Review
Richwood Investment Advisors increased its Pfizer (PFE) stake by 13% in Q2 2026, buying an estimated $51.4K and bringing the position to 17,470 shares worth $421K. The position accounts for 0.3% of the portfolio, ranked #72.
Richwood Investment Advisors first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.39M in Q4 2021. 1,247 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Richwood Investment Advisors held 17,470 shares of Pfizer worth $421K as of Q2 2026.
- Richwood Investment Advisors bought 1,966 Pfizer shares in Q2 2026, an estimated $51.4K.
- Pfizer made up 0.3% of Richwood Investment Advisors's portfolio in Q2 2026, its #72 holding.
- Richwood Investment Advisors first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
- Richwood Investment Advisors's Pfizer position peaked at $1.39M in Q4 2021.
- 1,247 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Richwood Investment Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.